Naproxen + DomperidoneThird Party Manufacturing in India

Naproxen + Domperidone works through a dual mechanism that combines potent analgesic and anti-inflammatory activity with gastrointestinal prokinetic action, making it specifically suited for migraine and headache disorders where both pain relief and gastric stasis management are needed. Naproxen, a nonsteroidal anti-inflammatory drug of the propionic acid class, inhibits both cyclooxygenase-1 and cyclooxygenase-2 enzymes, blocking the conversion of arachidonic acid into prostaglandins that sensitize pain receptors and promote inflammation. In migraine, naproxen helps reduce the neurogenic inflammation of cranial blood vessels and blocks pain signaling in the trigeminovascular system. Domperidone acts as a dopamine D2 receptor antagonist in the chemoreceptor trigger zone and at the gastric level. Unlike metoclopramide, domperidone does not readily cross the blood-brain barrier, making it less likely to cause extrapyramidal side effects. At the gastric level, domperidone increases lower esophageal sphincter pressure, enhances gastric peristalsis, and accelerates gastric emptying, which is particularly important in migraine because migraine attacks frequently cause gastroparesis — delayed stomach emptying that impairs absorption of oral medications. By improving gastric motility, domperidone ensures that naproxen is absorbed more reliably and rapidly, enhancing the overall therapeutic effect.

Therapeutic Uses

Naproxen + Domperidone is prescribed for:

• Acute Migraine Attacks: Relieving headache pain, photophobia, and phonophobia while simultaneously treating the nausea and gastric stasis that commonly accompany migraine episodes.
• Tension-Type Headache: Providing relief for moderate to severe tension headaches where there is associated gastric discomfort or nausea.
• Dysmenorrhea with Nausea: Managing painful menstrual cramps accompanied by gastrointestinal symptoms like nausea, vomiting, or bloating.
• Post-Surgical Pain with Ileus: Treating postoperative pain where there is concurrent gastrointestinal motility dysfunction.

Why Manufacturers Choose Naproxen + Domperidone

This fixed-dose combination addresses the specific clinical challenge of treating migraine and headache disorders where gastric stasis is a significant barrier to effective oral therapy. Migraine affects approximately 15% of the global population, creating a massive and recurring patient base. The combination of an NSAID with a prokinetic agent improves the absorption and efficacy of the analgesic component, giving clinicians a rational and convenient single-tablet solution. The 250mg + 10mg and 500mg + 10mg strengths cover the standard dosing spectrum from mild to severe attacks. For Indian third-party manufacturers, this combination represents a steady-demand product in the neurology and pain management segment, prescribed by neurologists, general practitioners, and gynecologists. The tablet formulation requires standard manufacturing capabilities with attention to content uniformity of the low-dose domperidone component.

This makes Naproxen + Domperidone one of the most sought-after analgesic combinations for third party manufacturing in India.